指南与共识消化、代谢与肾脏急症儿科与产科急症

ACR适宜性标准®急性肾盂肾炎:2022更新版

ACR Appropriateness Criteria® Acute Pyelonephritis: 2022 Update.
指南 / 共识 · J Am Coll Radiol · 2022-01-01
一句话结论ACR指南:初次疑似无并发症急性肾盂肾炎不推荐初始影像学检查;高危患者首选CT、MRI和超声,妊娠无并发症者初始CT通常不适宜。

急性肾盂肾炎(APN)是严重尿路感染,可致脓毒症、休克和死亡。多数无并发症APN可临床诊断并对适当抗生素治疗有反应,但高危患者或治疗延迟时微脓肿可融合形成急性肾脓肿;高危因素包括既往肾盂肾炎史、下尿路感染或APN治疗无反应、糖尿病、泌尿系统解剖或先天异常、耐药菌感染、医院获得性感染、尿石症、肾梗阻、既往肾脏手术、高龄、妊娠、肾移植受者和免疫抑制或免疫功能低下患者。影像学常用于辅助诊断、识别诱因、区分下尿路感染与肾实质受累,尤其对高危个体;但初次疑似无并发症APN通常不适宜影像学检查。高危疑似APN患者主要影像学方法为CT、MRI和超声,但妊娠无其他并发症者初始CT通常不适宜。ACR适宜性标准为循证指南,由多学科专家小组每年审查,采用GRADE和RAND/UCLA适宜性方法学。

要点

  • 首次疑似无并发症APN不推荐初始影像学检查,多数可临床诊断并对适当抗生素有反应。
  • 高危患者(如既往肾盂肾炎史、糖尿病、尿路梗阻、尿石症、肾移植、免疫抑制、妊娠、高龄)或治疗延迟时,微脓肿可融合形成急性肾脓肿。
  • 高危疑似APN患者主要影像学方法为CT、MRI和超声;妊娠无其他并发症者初始CT通常不适宜。
  • 妊娠和接受免疫抑制治疗的肾移植患者发生严重并发症风险升高。
  • 影像学用于辅助诊断、识别诱因及区分下尿路感染与肾实质受累,尤其针对高危个体。

适用人群与场景

  • 急性肾盂肾炎(APN)患者;多数无并发症APN可临床诊断并对适当抗生素治疗有反应。
  • 高危患者包括:既往肾盂肾炎史、下尿路感染或APN治疗无反应、糖尿病、泌尿系统解剖或先天异常、耐药菌感染、医院获得性感染、尿石症、肾梗阻、既往肾脏手术、高龄、妊娠、肾移植受者、免疫抑制或免疫功能低下患者。
  • 妊娠患者和接受免疫抑制治疗的肾移植患者发生严重并发症的风险升高。

处置流程与药物剂量

  • 多数无并发症APN:临床诊断,对适当抗生素治疗有反应;首次疑似无并发症APN通常不适宜初始影像学检查。
  • 高危疑似APN患者:主要影像学方法为CT、MRI和超声;影像学用于辅助诊断、识别诱因、区分下尿路感染与肾实质受累。
  • 妊娠无其他并发症的患者:初始CT通常不适宜。

红旗征与不能漏的情况

  • 高危患者或治疗延迟时,微脓肿可融合形成急性肾脓肿。
  • APN可导致脓毒症、休克和死亡。
  • 妊娠患者和接受免疫抑制治疗的肾移植患者发生严重并发症的风险升高。

研究设计与关键结果

  • ACR适宜性标准为针对特定临床情况的循证指南,由多学科专家小组每年审查。
  • 指南制定与修订过程支持对同行评审期刊医学文献进行系统分析,采用GRADE等既定方法学原则评价证据。
  • RAND/UCLA适宜性方法用户手册提供方法学,用于确定特定临床场景下影像学和治疗程序的适宜性。
  • 同行评审文献缺乏或模棱两可时,专家可能是制定推荐意见的主要证据来源。

证据类型、等级与局限

  • 证据类型:指南(ACR适宜性标准)。
  • 采用GRADE等既定方法学原则评价证据。
  • 采用RAND/UCLA适宜性方法确定影像学和治疗程序的适宜性。
  • 同行评审文献缺乏或模棱两可时,专家可能是主要证据来源。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 首次疑似无并发症APN患者不行初始影像学检查。
  • 高危疑似APN患者可行CT、MRI或超声检查以辅助诊断和识别诱因。
  • 妊娠无其他并发症患者初始不首选CT。

指南或共识出处

  • ACR Appropriateness Criteria® Acute Pyelonephritis: 2022 Update(J Am Coll Radiol)

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Acute pyelonephritis (APN) is a severe urinary tract infection (UTI) that has the potential to cause sepsis, shock, and death. In the majority of patients, uncomplicated APN is diagnosed clinically and is responsive to treatment with appropriate antibiotics. In patients who are high risk or when treatment is delayed, microabscesses may coalesce to form an acute renal abscess. High-risk patients include those with a prior history of pyelonephritis, lack of response to therapy for lower UTI or for APN, diabetes, anatomic or congenital abnormalities of the urinary system, infections by treatment-resistant organisms, nosocomial infection, urolithiasis, renal obstruction, prior renal surgery, advanced age, pregnancy, renal transplant recipients, and immunosuppressed or immunocompromised patients. Pregnant patients and patients with renal transplants on immunosuppression are at an elevated risk of severe complications. Imaging studies are often requested to aid with the diagnosis, identify precipitating factors, and differentiate lower UTI from renal parenchymal involvement, particularly in high-risk individuals. Imaging is usually not appropriate for the first-time presentation of suspected APN in an uncomplicated patient. The primary imaging modalities used in high-risk patients with suspected APN are CT, MRI, and ultrasound, although CT was usually not appropriate for initial imaging in a pregnant patient with no other complications. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer-reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances in which peer-reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

参考来源

  1. Smith AD, Nikolaidis P, Khatri G, et al. ACR Appropriateness Criteria® Acute Pyelonephritis: 2022 Update. J Am Coll Radiol. 2022. PMID: 36436954. doi:10.1016/j.jacr.2022.09.017

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。